Blueprint Medicines Corp (BPMC) Insider Trading

Total insider buys:
  • $348,278.00
Total insider sells:
  • $172,506,150.80
Most recent insider trade:
  • Nov. 29, 2024
Most active insider trader:
  • Jeffrey W Albers
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 16, 2019Insider415$75.00Sell$31,125.00
Dec. 4, 2019Insider192$77.25Sell$14,832.00
Nov. 18, 2019CEO8,256$75.42Sell$622,667.52
Nov. 8, 2019CEO11,744$74.56Sell$875,632.64
Oct. 17, 2019Insider415$75.00Sell$31,125.00
Sept. 16, 2019Insider415$78.14Sell$32,428.10
Aug. 21, 2019Insider10,000$80.07Sell$800,700.00
Aug. 19, 2019CEO20,000$81.73Sell$1,634,600.00
Aug. 19, 2019COO95$85.00Sell$8,075.00
Aug. 15, 2019Insider415$84.02Sell$34,868.30
Aug. 15, 2019Director10,000$82.40Sell$824,000.00
July 19, 2019Insider115$100.00Sell$11,500.00
July 16, 2019COO1,571$95.47Sell$149,983.37
July 15, 2019Insider830$94.98Sell$78,833.40
July 8, 2019Insider10,000$93.88Sell$938,800.00
June 27, 2019Director21,818$92.01Sell$2,007,474.18
June 20, 2019Director11,818$95.15Sell$1,124,482.70
June 17, 2019COO11,952$96.46Sell$1,152,889.92
June 17, 2019Insider1,405$98.22Sell$137,999.10
June 17, 2019Director1,136$98.50Sell$111,896.00
June 17, 2019CEO5,000$99.06Sell$495,300.00
June 13, 2019Insider2,733$88.04Sell$240,613.32
June 12, 2019CEO20,000$84.75Sell$1,695,000.00
June 12, 2019Director25,000$84.77Sell$2,119,250.00
March 15, 2019Insider415$85.55Sell$35,503.25
March 15, 2019CEO20,000$86.39Sell$1,727,800.00
March 4, 2019Insider2,300$84.66Sell$194,718.00
March 1, 2019COO21,644$85.05Sell$1,840,822.20
Nov. 5, 2018CEO20,000$63.49Sell$1,269,800.00
Sept. 17, 2018Insider2,300$70.47Sell$162,081.00
Aug. 6, 2018CEO20,000$70.59Sell$1,411,800.00
May 7, 2018CEO20,000$78.90Sell$1,578,000.00
March 19, 2018Director5,492$100.09Sell$549,694.28
March 15, 2018Insider2,300$100.07Sell$230,161.00
March 2, 2018CEO20,000$92.57Sell$1,851,400.00
Feb. 28, 2018Director25,000$87.89Sell$2,197,250.00
Feb. 14, 2018Director12,500$80.42Sell$1,005,250.00
Feb. 12, 2018Director17,500$74.84Sell$1,309,700.00
Feb. 12, 2018Insider6,775$74.93Sell$507,650.75
Nov. 21, 2017Insider18,334$65.45Sell$1,199,960.30
Nov. 15, 2017Director5,000$63.38Sell$316,900.00
Nov. 6, 2017Insider5,000$70.40Sell$352,000.00
Nov. 6, 2017CEO30,000$70.31Sell$2,109,300.00
Oct. 5, 2017Insider5,449$66.44Sell$362,031.56
Sept. 18, 2017Director2,500$60.00Sell$150,000.00
Sept. 18, 2017Insider6,356$60.03Sell$381,550.68
Aug. 9, 2017Insider5,000$48.60Sell$243,000.00
Aug. 8, 2017CEO30,000$49.62Sell$1,488,600.00
Aug. 7, 2017CEO20,000$49.08Sell$981,600.00
July 5, 2017Insider7,265$54.66Sell$397,104.90
  • Insiders are both buying and selling Blueprint Medicines Corp stock.

  • The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Daniel Lynch, L. Becker Hewes, Christopher K Murray, Marion Dorsch, Anthony L Boral, Debra Durso-Bumpus, Nicholas Lydon, George Demetri, Tracey L Mccain, Christina Rossi, Fmr Llc, Michael Landsittel, Christoph Lengauer, Mark Alan Goldberg, Fouad Namouni, Percy H Carter, Charles A Rowland Jr, Rock Ventures Ii L.P. Third, Kevin P. Starr, Lonnel Coats, Mark J Levin, Alexis Borisy, and Philina Lee

  • The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 38 trades.

  • Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.

  • Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.

  • The most recent insider trade for Blueprint Medicines Corp was on Nov. 29, 2024.

  • The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.

  • The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.